Search Results

There are 7880 results for: content related to: Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm

  1. Using translational medicine to understand clinical differences between botulinum toxin formulations

    European Journal of Neurology

    Volume 13, Issue s4, December 2006, Pages: 10–19, K. R. Aoki, D. Ranoux and J. Wissel

    Article first published online : 13 NOV 2006, DOI: 10.1111/j.1468-1331.2006.01649.x

  2. Comparing two botulinum toxin type A formulations using manufacturers’ product summaries

    Journal of Clinical Pharmacy and Therapeutics

    Volume 32, Issue 4, August 2007, Pages: 387–402, R. Wenzel, D. Jones and J. A. Borrego

    Article first published online : 17 JUL 2007, DOI: 10.1111/j.1365-2710.2007.00835.x

  3. You have full text access to this OnlineOpen article
    Dysport and Botox at a ratio of 2.5:1 units in cervical dystonia: A double-blind, randomized study

    Movement Disorders

    Ji Young Yun, Jae Woo Kim, Hee-Tae Kim, Sun Ju Chung, Jong-Min Kim, Jin Whan Cho, Jee-Young Lee, Ha Neul Lee, Sooyeoun You, Eungseok Oh, Heejeong Jeong, Young Eun Kim, Han-Joon Kim, Won Yong Lee and Beom S. Jeon

    Article first published online : 5 DEC 2014, DOI: 10.1002/mds.26085

  4. Pharmacology of botulinum toxin: differences between type A preparations

    European Journal of Neurology

    Volume 13, Issue s1, February 2006, Pages: 2–10, R. L. Rosales, H. Bigalke and D. Dressler

    Article first published online : 15 SEP 2008, DOI: 10.1111/j.1468-1331.2006.01438.x

  5. You have free access to this content
    Abstracts of The Movement Disorder Society's Eleventh International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 22, Issue S16, 2007, Pages: S1–S325,

    Article first published online : 24 APR 2007, DOI: 10.1002/mds.21535

  6. Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement

    European Journal of Neurology

    Volume 17, Issue s2, August 2010, Pages: 9–37, S. C. Love, I. Novak, M. Kentish, K. Desloovere, F. Heinen, G. Molenaers, S. O’Flaherty and H. K. Graham

    Article first published online : 15 JUL 2010, DOI: 10.1111/j.1468-1331.2010.03126.x

  7. A double-blind, randomized, comparative study of Dysport® vs. Botox® in primary palmar hyperhidrosis

    British Journal of Dermatology

    Volume 149, Issue 5, November 2003, Pages: 1041–1045, M. Simonetta Moreau, C. Cauhepe, J.P. Magues and J.M. Senard

    Article first published online : 24 NOV 2003, DOI: 10.1111/j.1365-2133.2003.05620.x

  8. Clinical comparability of marketed formulations of botulinum toxin

    Movement Disorders

    Volume 19, Issue S8, March 2004, Pages: S129–S136, Cristina Sampaio, João Costa and Joaquim J. Ferreira

    Article first published online : 9 MAR 2004, DOI: 10.1002/mds.20066

  9. Five-year experience with incobotulinumtoxinA (Xeomin®): the first botulinum toxin drug free of complexing proteins

    European Journal of Neurology

    Volume 19, Issue 3, March 2012, Pages: 385–389, D. Dressler

    Article first published online : 28 OCT 2011, DOI: 10.1111/j.1468-1331.2011.03559.x

  10. A Double-Blind, Randomized, Comparative Study of Two Type A Botulinum Toxins in the Treatment of Primary Axillary Hyperhidrosis

    Dermatologic Surgery

    Volume 33, Issue s1, January 2007, Pages: S44–S50, SÉRGIO TALARICO-FILHO, MAURÍCIO MENDONÇA DO NASCIMENTO, FERNANDO SPERANDEO DE MACEDO and CARLA DE SANCTIS PECORA

    Article first published online : 2 JAN 2007, DOI: 10.1111/j.1524-4725.2006.32331.x

  11. Botulinum Toxin Type A for Facial Rejuvenation

    Dermatologic Surgery

    Volume 24, Issue 11, November 1998, Pages: 1216–1218, NICHOLAS J. LOWE

    Article first published online : 19 JUN 2013, DOI: 10.1111/j.1524-4725.1998.tb04100.x

  12. Botulinum toxin A in the overactive bladder: current status and future directions

    BJU International

    Volume 99, Issue 2, February 2007, Pages: 247–262, Roger Dmochowski and Peter K. Sand

    Article first published online : 19 JAN 2007, DOI: 10.1111/j.1464-410X.2007.06575.x

  13. Retrospective evaluation of the dose of dysport and BOTOX in the management of cervical dystonia and blepharospasm: The REAL DOSE study

    Movement Disorders

    Volume 20, Issue 8, August 2005, Pages: 937–944, Albert Marchetti, Raf Magar, Leslie Findley, Jan P. Larsen, Zvezdan Pirtosek, Evzen Råužižka, Robert Jech, Jaroslaw Sławek and Fayyaz Ahmed

    Article first published online : 4 APR 2005, DOI: 10.1002/mds.20468

  14. DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1

    Movement Disorders

    Volume 12, Issue 6, November 1997, Pages: 1013–1018, Dr. Cristina Sampaio, Joaquim J. Ferreira, Fernanda Simões, Maria J. Rosas, Marina Magalhães, Ana P. Correia, António Bastos-Lima, Rairnundo Martins and Alexandre Castro-Caldas

    Article first published online : 4 NOV 2004, DOI: 10.1002/mds.870120627

  15. Xeomin® in the treatment of cervical dystonia

    European Journal of Neurology

    Volume 16, Issue s2, December 2009, Pages: 6–10, R. Benecke

    Article first published online : 7 DEC 2009, DOI: 10.1111/j.1468-1331.2009.02878.x

  16. Immunological aspects of Botox®, Dysport® and MyoblocTM/NeuroBloc®

    European Journal of Neurology

    Volume 13, Issue s1, February 2006, Pages: 11–15, D. Dressler and M. Hallett

    Article first published online : 15 SEP 2008, DOI: 10.1111/j.1468-1331.2006.01439.x

  17. You have free access to this content
    Current Evidence on the Unit Equivalence of Different Botulinum Neurotoxin A Formulations and Recommendations for Clinical Practice in Dermatology

    Dermatologic Surgery

    Volume 35, Issue 1, January 2009, Pages: 1–8, SYRUS KARSAI and CHRISTIAN RAULIN

    Article first published online : 3 NOV 2008, DOI: 10.1111/j.1524-4725.2008.34375.x

  18. Poster session 6: Clinical electrophysiology, dystonia

    Movement Disorders

    Volume 17, Issue S5, November 2002, Pages: S264–S310,

    Article first published online : 21 OCT 2002, DOI: 10.1002/mds.10354

  19. Is there a direct antimicrobial effect of botulinum neurotoxin type A?

    BJU International

    Volume 110, Issue 11c, December 2012, Pages: E886–E890, Jens Wöllner, Kathrin Schmidig, Flavia Gregorini, Thomas M. Kessler, Reinhard Zbinden and Ulrich Mehnert

    Article first published online : 9 AUG 2012, DOI: 10.1111/j.1464-410X.2012.11414.x

  20. Botulinum toxin type A therapy for cervical dystonia

    Intervention Review

    The Cochrane Library

    João Costa, Cláudia C Espírito-Santo, Ana A Borges, Joaquim Ferreira, Miguel M Coelho, Peter Moore and Cristina Sampaio

    Published Online : 24 JAN 2005, DOI: 10.1002/14651858.CD003633.pub2